Status:
UNKNOWN
Identifying Neuroimaging Biomarkers, Demographic, Personality and Sensory Factors for Predicting Extreme Pain Responses to Various Experimental Pain Stimulations in Healthy Subjects
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Pain
Individual Difference
Eligibility:
All Genders
18+ years
Brief Summary
The proneness to react to noxious stimuli varies widely between individuals and pain ratings of seemingly identical noxious stimuli may range from "no pain" to "excruciating pain" . Imaging studies in...
Detailed Description
Background The proneness to react to noxious stimuli varies widely between individuals and pain ratings of seemingly identical noxious stimuli may range from "no pain" to "excruciating pain" . Imaging...
Eligibility Criteria
Inclusion
- Healthy males and females, over the age of 18, free from chronic pain of any type.
- No medication use (except for oral contraceptives).
- Able to understand the purpose and instructions of the study and to sign an informed consent.
Exclusion
- Pregnant women
- Inability to comply with study protocol.
- A diagnosis of Raynaud's Syndrome
- Subjects with metal implants of any kind (including pace maker) and Claustrophobia will be excluded from the study.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03436264
Start Date
March 1 2018
End Date
December 1 2019
Last Update
April 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096